Lindhardt B O, Lauritzen E, Ulrich K, Kvinesdal B, Pedersen C, Gaub J, Wantzin G L, Scheibel E
Laboratory of Tumor Virology, Fibiger Institute, Hvidovre Hospital, Copenhagen, Denmark.
Scand J Infect Dis. 1989;21(5):491-6. doi: 10.3109/00365548909037876.
39 persons with an incidentally discovered seroconversion from HIV antibody negative (Ab-) to antibody positive (Ab+) state as measured by an enzyme-linked immunosorbent assay (ELISA) were investigated for the presence of (1) HIV antigen (Ag) and (2) immunoblotting test (IBT) Ab in serum samples collected within the year before seroconversion. 13 (33%) of the patients were HIV Ag+ at some time before seroconversion. However, the collection of samples was not done systematically and the samples from patients who had at least 1 sample collected within 3 months before seroconversion were thus compiled separately. This group consisted of 58 samples from 19 patients and among these none were HIV Ag+ earlier than 11 weeks before seroconversion, but the prevalence of HIV Ag+ samples was rising towards seroconversion and 10 patients (53%, 95% confidence limits: 29-76%) became HIV Ag+ in this 11-week period. Further, among all patients 13 (33%) were IBT Ab+ 4-50 days (median: 14 days) before seroconversion. Finally, among 18 patients with signs and symptoms consistent with an acute HIV infection 10 were HIV Ag+, as opposed to 4 HIV Ag+ patients among 21 without symptoms (p = 0.041).
对39例通过酶联免疫吸附测定(ELISA)偶然发现从HIV抗体阴性(Ab-)血清转化为抗体阳性(Ab+)状态的患者,检测其在血清转化前一年采集的血清样本中是否存在(1)HIV抗原(Ag)和(2)免疫印迹试验(IBT)抗体。13例(33%)患者在血清转化前的某个时间点为HIV Ag+。然而,样本采集并非系统进行,因此将血清转化前3个月内至少采集过1份样本的患者样本单独汇总。该组包括19例患者的58份样本,其中在血清转化前11周内均无HIV Ag+,但HIV Ag+样本的患病率在血清转化前呈上升趋势,10例患者(53%,95%置信区间:29 - 76%)在此11周内变为HIV Ag+。此外,所有患者中,13例(33%)在血清转化前4 - 50天(中位数:14天)为IBT抗体阳性。最后,在18例有急性HIV感染体征和症状的患者中,10例为HIV Ag+,而21例无症状患者中有4例为HIV Ag+(p = 0.041)。